Compare CEPU & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CEPU | LMAT |
|---|---|---|
| Founded | 1989 | 1983 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2017 | 2006 |
| Metric | CEPU | LMAT |
|---|---|---|
| Price | $14.38 | $106.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $17.50 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 349.7K | 136.7K |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 2.52 |
| Revenue | N/A | ★ $249,602,000.00 |
| Revenue This Year | $10.11 | $14.21 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | ★ $12.24 | $44.56 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $7.43 | $78.01 |
| 52 Week High | $18.50 | $118.01 |
| Indicator | CEPU | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 37.32 | 41.52 |
| Support Level | $13.78 | $104.00 |
| Resistance Level | $18.22 | $113.40 |
| Average True Range (ATR) | 0.59 | 3.22 |
| MACD | -0.17 | -0.88 |
| Stochastic Oscillator | 9.07 | 0.62 |
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.